Mitesh Borad

Appearances

ADJUVANT CHEMOTHERAPY IS NOT ASSOCIATED WITH IMPROVED OVERALL SURVIVAL IN PATIENTS WITH PANCREATIC DUCTAL ADENOCARCINOMA WITH PERSISTENT LYMPHOVASCULAR INVASION OR LYMPH NODE INVOLVEMENT AFTER NEOADJUVANT CHEMOTHERAPY
Date
May 19, 2024
The role of adjuvant chemotherapy (AC) after neoadjuvant treatment (NAT) for patients with pancreatic ductal adenocarcinoma (PDAC) is not well-defined…
Presenter
Valerie Armstrong
Speakers
Yu-Hui Chang
Akash Kartik
Chee-Chee Stucky
Rish Pai
Mohamad Sonbol
Christina Wu
Mitesh Borad
Tanios Bekaii-Saab
Nabil Wasif
Zhi Ven Fong